One of the major hurdles facing the application of adenoviral gene transfer to skeletal muscle is the maturation-dependent transduction of muscle myofibers. It was recently proposed that the viral receptors (Coxsackie and adenovirus receptor (CAR) and the integrins ␣v␤3/␤5) play a major role in the poor adenoviral transduction of mature myofibers. Here we report the findings of morphological studies designed to determine experimentally the role of receptors in the adenoviral transduction of mature myofibers. First, we observed that the expression of both attachment and internalization receptors did not change significantly during muscle development. Second, when an extended tropism adenoviral vector (AdPK) that attaches to heparan sulfate proteoglycan
Introduction
Two major approaches have been investigated to deliver genes to skeletal muscle: myoblast transplantation and gene therapy. Myoblast transplantation (MT) has been found efficient to deliver genes to skeletal muscle, but the success of this technique has been hindered by immune rejection, poor spread, and the limited survival of injected myoblasts after transplantation. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Consequently, strategies for delivering genes to skeletal muscle using viral/nonviral vectors have evolved rapidly. The intramuscular injection of nonviral vectors (plasmid DNA) to deliver genes to muscle has shown the advantage of long-term persistence. 11 Although progress has been made in improving nonviral gene transfer efficiency, including the development of condensation of plasmid DNA with polylysine, the injection of DNA at the myotendinous junction, and the use of electric pulses, this approach still remains limited for skeletal muscle.
(HSP) is used, a significant reduction of adenoviral transduction still occurs in mature myofibers despite HSP's high expression in mature skeletal muscle fibers. Third, when the adeno-associated virus (AAV) is used, which also utilizes HSP as a viral receptor, muscle fibers at different maturities can be highly transduced. Fourth, the pre-irradiation of the skeletal muscle of newborn mice to inactivate myoblasts dramatically decreased the transduction level of Ad and AdPK, but had no effect on AAV-mediated viral transduction of immature myofibers. These results taken together suggest that the viral receptor(s) is not a major determinant in maturation-dependent adenoviral transduction of myofibers. Gene Therapy (2001) 8, 627-637. studied extensively. Retroviral vectors (RV) are relatively safe and can infect dividing myoblasts (progenitors of muscle fiber) with a high efficiency. [16] [17] [18] In addition, the ability of retroviruses to become stably integrated into the host cell genome can provide long-term, stable expression of the delivered gene. However, retrovirus remains incapable of infecting post-mitotic cells. 16, 19 Muscle cells become post-mitotic very early in their development, and the mature muscle tissue has no actively dividing cells unless injured or affected by a genetic dystrophy. Therefore, muscle shows a dramatic loss of retroviral transduction during maturation. 20 Other limitations to the use of retroviruses are the gene insert capacity (less than 7 kb), the relatively low titers (10 5 -10 6 p.f.u./ml), and the risk of insertional mutagenesis.
Viral vectors derived from the herpes simplex virus type 1 (HSV-1) are naturally capable of carrying large DNA fragments, such as the 14 kb dystrophin cDNA, and they have been studied for their ability to transduce muscle cells. [20] [21] [22] Herpes simplex viral vectors, which can persist in the host cell in a nonintegrated state and be prepared at adequately high titers (10 7 -10 9 p.f.u./ml), have shown efficient transduction of myoblasts, myotubes, and immature myofibers. However, HSV-1-based vectors are still unable to highly penetrate and transduce mature myofibers. [20] [21] [22] Recombinant adeno-associated viral vectors (AAV) have also been used as gene delivery vehicles for muscle cells. [23] [24] [25] [26] [27] Although a long-term transgene expression (up to 18 months) and a high efficiency of mature myofiber transduction have been observed in mouse skeletal muscle, [23] [24] [25] [26] [27] the application of adeno-associated viral vectors for gene therapy purposes may be limited by their restrictive gene insert capacity.
Adenoviral (Ad) vectors have held a prominent position in efforts to deliver therapeutic genes to skeletal muscle; however, various hurdles have been identified in the application of adenovirus as a gene delivery vehicle to skeletal muscle. [28] [29] [30] [31] [32] [33] [34] [35] The major limitations facing firstgeneration adenoviral gene transfer to skeletal muscle are (1) the lack of transgene persistence due to the immune rejection of transduced myofibers; (2) the low insert carrying capacity; (3) the reduced viral transducibility during muscle maturation; and (4) repeated administration associated with the production of neutralizing antibodies is limited to the viral capsid.
New mutant Ad vectors lacking all viral genes show a markedly decreased immunogenicity and hence, an improved persistence of transgene expression in muscle in vivo. [28] [29] [30] These observations suggest that the limitations regarding the immunogenicity with the use of adenoviral vectors are being overcome. However, the inability of adenoviral vectors to efficiently transduce mature myofibers remains a major hurdle facing the widespread application of adenoviral gene transfer to skeletal muscle. 20, 31, 36 It has been reported that the extracellular matrix of mature myofibers may form a physical barrier and prevent the passage of some viral particles that are too big to pass through its pores, which are estimated at 40 nm in size. 37 Adenoviral particles are about 70 nm and 100 nm in diameter and appear to be too large to penetrate the pores of the basal lamina. We therefore recently investigated whether the use of smaller viral vectors, such as AAV, could overcome the maturation-dependent viral transduction of muscle fibers. Indeed, we observed that the use of smaller viruses, such as AAV, could efficiently penetrate and transduce mature myofibers. 24 Since the adenovirus (Ad) transduction of cells is receptor-mediated, 38, 39 it was recently proposed that the viral receptors play a major role in the maturation-dependent adenoviral transduction of myofibers. 40 Indeed, reports showed that transfection of mouse CAR (Coxsackie and adenovirus receptor, the attachment receptor) cDNA into NIH 3T3 cells, which are CAR deficient, is sufficient to confer susceptibility to subgroup C Ad and CVB (group B Coxsackievirus) infection. 39 There are inconsistencies, however, regarding the relative importance of the basal lamina and/or receptors in the maturation-dependent adenoviral transduction of myofibers. In fact, it has been reported that low expression of CAR is responsible for the low efficiency of myofiber transduction. 40 However, it was also recently reported that in tissues other than skeletal muscle, expression of attachment and internalization receptors does not correlate with adenoviral targeting in vivo, indicating anatomical vector barriers. 41 Indeed, we have observed that the basal lamina and the quiescence of myoblasts during muscle maturation are major barriers for large virus penetration, while the level of CAR was not significantly reduced in mature myofibers. 20, 36, 42, 43 Similarly, it has been reported that free cholesterol enhanced adenoviral vector gene transfer and expression in CAR-deficient cells by (1) the formation of multivirus aggregates due to hydrophobic interaction between cholesterol-coated Ad particles; and (2) the formation of a complex that exhibited increased binding and uptake into the cells. 44 Surprisingly, this increase of Ad vectormediated gene transfer with cholesterol was independent of the CAR receptor expression on the cell surface and was, in contrast, diminished by overexpression of the viral receptors in CAR-deficient cells. 44 Other receptors for the adenovirus are the internalization receptors, integrins ␣v␤3/␤5. Previous studies reported that integrin ␣v is expressed at similar levels in muscle at different maturities. 34 However, it was observed that ␤3/␤5 was decreased when myoblasts differentiated into myotubes, but the decrease of the receptor did not fully correlate with the decrease of transduction efficiency. 35 All these results taken together made us question the role of the adenoviral receptors in the maturation-dependent adenoviral transduction of myofibers. The purpose of this study was to characterize the mechanism(s) involved in the poor efficiency of adenoviral transduction in mature muscle fibers. We then investigated the relative importance of adenoviral receptors (attachment CAR and internalization integrins ␣v␤3/␤5) in limiting adenoviral transduction of mature myofibers.
Results
Integrins ␣v and ␤5 expression in myoblasts and myotubes in vitro ( Figure 1 ) Myoblasts from both newborn (NB) and adult (AD) mouse skeletal muscle were isolated. By using antibodies against integrins ␣v and ␤5, we found that both isotypes are expressed in myoblasts originated from newborn ( Figure 1a , b) and adult skeletal muscle (Figure 1c, d ). No significant difference was observed in the expression levels of integrins ␣v (NB 413 ± 14, AD 426 ± 17, P Ͼ 0.05, n = 6) and ␤5 (NB 454 ± 21, AD 462 ± 27, P Ͼ 0.05, n = 6) in myoblasts originated from muscle fibers of newborn and adult mice (Figure 1a-d) .
Furthermore, we investigated the expression levels of integrins ␣v and ␤5 in differentiated myotubes formed by the fusion of myoblasts originated from newborn (Figure 1e , f) and adult (Figure 1g , h) skeletal muscle. Similarly, immunohistochemical staining did not reveal any difference in the levels of ␣v (NB 462 ± 27, AD 447 ± 25, P Ͻ 0.05, no significance, n = 6) and ␤5 (NB 482 ± 31, AD 479 ± 29, P Ͼ 0.05, no significance, n = 6) expression in myotubes (Figure 1e-h ).
Integrins ␣v and ␤5 expression in myofibers in vitro and in vivo (Figure 2 ) We further investigated the integrin expression levels in intact viable myofibers that were isolated from newborn and adult skeletal muscle. Positive staining with integrins ␣v and ␤5 was observed in myofibers isolated from newborn and adult skeletal muscle (Figure 2a-d) . Similarly, no significant difference in the levels of integrins ␣v (NB 471 ± 28, AD 492 ± 34, P Ͼ 0.05, n = 6) and ␤5 (NB 431 ± 14, AD 419 ± 16, P Ͼ 0.05, n = 6) was observed in myofibers derived from newborn and adult mice ( Figure  2a-d) .
Finally, the levels of integrin expression were also investigated in newborn and adult skeletal muscle in vivo. We similarly observed that in myofibers from both newborn and adult mice, integrins ␣v (NB 472 ± 15, AD 452 ± 26, P Ͼ 0.05, no significance, n = 6) and ␤5 (NB 482 ± 31, AD 491 ± 28, P Ͼ 0.05, no significance, n = 6) were expressed at similar levels (Figure 2e-h ).
Integrins ␣v, ␤3, and ␤5 and CAR expression in myofibers from normal newborn and adult mice ( Figures  3 and 4) Immunocytochemical results showed that CAR is also expressed at similar levels in both newborn ( Figure 3a ) and adult muscle (Figure 3b ). By using a semi-quantitative RT-PCR technique combined with NIH image software to determine the band density, we also observed that the integrins ␣v, ␤3, and ␤5 and CAR receptors did not change significantly between newborn and adult skeletal muscle of normal mice (Figure 4a , b). To further quantitate CAR expression, we performed real-time PCR using LightCycler. The result showed that, using the same amount of RNA/cDNA, the PCR product of CAR is 0.135 (arbitrary unit, AU, calibrated by ␤-actin) from newborns, and 0.121 AU from adult muscles. The difference is about 10% and therefore cannot correlate with the differential adenoviral transduction levels between neonatal and adult muscle. These results in combination with Gene Therapy Importantly, most of the adenoviral transduction observed in the myotube cell culture appeared to be restricted to some residual nondifferentiated myoblasts ( Figure 5c , d, see arrows). This higher level of adenoviral transduction in myoblasts than in myotubes was previously suggested to be related to the higher level of ␣v␤3/␤5-integrin internalization receptors expressed in myoblasts when compared with myotubes. 35 However, the similar levels of the integrins ␣v and ␤5 observed in myoblasts and myotubes in this study did not support this contention.
Adenovirus generated high levels of transduction in results suggest that despite the similar levels of integrins ␣v and ␤5 and CAR expressed in newborn and adult skeletal muscle, Ad and AdPK cannot efficiently transduce adult skeletal muscle. This observation supports the idea that anatomical barriers may be involved in the poor adenoviral transduction of mature myofibers.
Figure 5 Adenoviral transduction in myoblasts (a, b), myotubes (c, d), and isolated myofibers (e, f) derived from newborn (a, c, e) and adult skeletal muscle (b, d, f). The same multiplicity of infection (MOI) was used to transduce myoblasts (a, b), myotubes (c, d), and myofibers (e, f) isolated from newborn (a, c, e) and adult skeletal muscles (b, d, f). An efficient adenoviral transduction was observed in myoblasts originated from newborn (a) and adult (b) skeletal muscle. In contrast, a poor adenoviral transduction was observed in myotubes derived from either newborn (c) or adult skeletal muscle (d). Some nonfused myoblasts were adenovirally transduced in the myotube cell culture (c, d, see arrows). An efficient adenoviral transduction was observed in newborn myofibers (e) in contrast to mature myofibers (f). Note the large number of transduced myoblasts in the isolated

The effect of irradiation on the viral transduction efficiencies in immature myofibers (Figures 7 and 8)
To determine whether the high adenoviral transduction levels obtained in newborn muscle were mediated by myoblasts, we performed irradiation experiments on newborn mouse muscle before adenoviral injection to inactivate the myoblasts. The irradiation was done 1 day before adenoviral injection at a dose of 30 Gy of ␥-irradiation to hamper proliferation and fusion of the myoblasts. 20 In the nonirradiated newborn muscles, high adenoviral transduction was observed (Figure 7a ). However, the irradiated newborn muscles displayed a dramatic decrease in adenoviral transduction when compared with the nonirradiated muscles (Figure 7b) .
To further investigate whether the irradiation also hampers the transduction with other viral vectors, we performed the same experiments using AdPK and AAV, which both use heparan sulfate proteoglycan as an attachment receptor. We observed that pre-irradiation of the newborn skeletal muscle also significantly reduced Gene Therapy the transduction with AdPK when compared with nonirradiated muscle (Figure 7c, d) . In contrast, the intramuscular injection of AAV in newborn muscle that had been pre-irradiated did not decrease the level of AAV transduction when compared with the nonirradiated muscle (Figure 7e, f) .
The ␤-galactosidase assay (ONPG assay) was used to further quantitate the viral transduction in irradiated and nonirradiated newborn skeletal muscle. We observed a strong correlation between the ␤-galactosidase assay and the histological findings. More importantly, the differences of adenoviral transduction (natural tropism Ad and modified tropism AdPK) between irradiated and nonirradiated newborn skeletal muscle were indeed found to be significant (*P Ͻ 0.05, n = 6) ( Figure 8 ). This significant decrease of adenoviral transduction in the pre-irradiated newborn muscle suggested that the transduction with both vectors (Ad and AdPK) in newborn muscle was mainly mediated by myoblasts. In contrast, the similar AAV transduction in irradiated and nonirradiated newborn skeletal muscles suggested, as previously reported by our research group, 24 that this viral vector did not require myoblasts as a gene delivery vehicle to transduce myofibers.
The levels of adenoviral receptors (integrins ␣v␤3/␤5 and CAR) remain unchanged after irradiation (Figures 9  and 10 ) Immunostaining for integrins (␣v, ␤5) and CAR showed no significant change in irradiated and nonirradiated muscle ( Figure 9 ). RT-PCR also revealed no significant change in the levels of attachment (CAR) and internalization (␣v␤3/␤5) receptors between irradiated and nonirradiated newborn skeletal muscles ( Figure 10 ). Finally, we also performed real-time PCR to determine the level of CAR expression in newborn muscle (irradiated and nonirradiated), and observed that CAR expression was 0.122 AU in irradiated newborn muscle while it was 0.135 AU in the nonirradiated muscle. These results showed that although the adenoviral receptors are expressed at similar levels in both irradiated and nonirradiated new- born skeletal muscle, the adenoviral transduction (natural tropism Ad and modified tropism AdPK) can still vary dramatically. The ability of AAV to transduce immature irradiated myofibers in vivo suggests that the HSP expression is not altered by irradiation. Therefore, the inability of AdPK to transduce irradiated immature myofibers is probably independent of the HSP expression. These results taken together further substantiate that the adenoviral receptors played only a limited role in the maturation-dependent adenoviral transduction of skeletal myofibers.
Figure 9 Immunohistochemical staining of integrins ␣v (a, b) and ␤5 (c, d), and CAR (e, f) in irradiated and nonirradiated muscle. a, c, e, nonirradiated; b, d, f, irradiated. No significant changes in the levels of adenoviral receptors were observed between irradiated and nonirradiated neonatal muscles. Magnification, ×100.
Figure 10 RT-PCR analysis of adenoviral receptors' expression in irradiated and nonirradiated newborn muscles. No significant differences in the adenoviral receptors' expression levels were observed between the irradiated and nonirradiated newborn skeletal muscles. (a) Gel results; (b) analytical result of PCR bands. CAR, Coxsackie adenoviral receptor
Discussion
The maturation-dependent adenoviral transduction of skeletal muscle was recently reported to be highly dependent on the adenoviral receptors at the surface of the myofibers. 40 Our study suggests, as previously described for other tissues, 41 that adenoviral receptors do not correlate with the viral transduction in skeletal muscle at different maturities. Consequently, other factors, including the basal lamina and the lack of myoblast mediation, are likely involved with the poor adenoviral transduction in mature myofibers. Our study suggested that expression of adenoviral receptors (CAR and integrins ␣v␤3/␤5) did not change significantly during muscle development. These results suggest that the adenoviral receptor is consequently not a major determinant in the maturationdependent adenoviral transduction of myofibers. The salient features of our studies are as follows:
The adenoviral receptor expression does not correlate with the viral transduction in muscle cells at different maturities: Immunohistochemical staining, RT-PCR, and real-time PCR analyses of the adenoviral receptors indicate that receptors are similarly expressed in muscle cells at different maturities. Integrin receptors are known to play an important role in cell signaling processes. 45 Previous reports showed that during muscle differentiation in vitro, the ␤3/␤5 integrin level showed down-regulation in differentiated myotubes versus myoblasts. 35 On the other hand, the ␣v integrin level remained unchanged in myoblasts and myotubes. 35 Our result did not support this decrease of ␤5 expression in muscle cells at different maturities. The use of different antibodies in these experiments may explain the differential results obtained by the two research groups. However, the decrease of ␤3/␤5 expression did not fully correlate with the decrease of viral transduction in their study -ie the ratio of measured transducibility of myoblasts versus myotubes in vitro was about 10:1, while the ratio of ␤3/␤5 receptor levels in the same cell types was only about 3:1. 35 Hence these results, like ours, suggest that some other factors play a role in the maturation-dependent adenoviral transduction of myofibers.
Since viral transduction experiments showed that adenovirus transduces myoblasts efficiently in contrast to myotubes, we consequently hypothesized that other factors play a role in this poor adenoviral transduction of differentiated muscle cells. Myotubes possess a rudimentary extracellular matrix (ECM), 46 which may act as a major barrier to adenoviral transduction in differentiated muscle cells.
The in vitro transducibility of mouse muscle cells is consistent with the results in vivo. Newborn mouse muscles, which still contain many myoblasts, 47 are highly transducible by Ad-mediated gene transfer, unlike mature myofibers. It is also possible that most of the integrin ␣v␤3/␤5 in mature muscle fibers is normally occupied by proteins such as vitronectin that are expressed at high levels in the ECM. 48 A poor transduction level in mature myofibers is still observed with extended tropism AdPK virus: Modified Ad vectors that display an extended tropism to alternative internalization or attachment receptors were engineered. [49] [50] [51] In this study, we analyzed AdPK, a modified tropism Ad vector described by Wickham et al. 49 Because of the introduced polylysine stretch at the C-terminal end of the viral fiber protein, the extended tropism AdPK can attach to both heparan-containing attachment receptors and CAR, the native attachment receptors for the adenovirus. Since it has been reported that only low levels of the Ad attachment receptor (CAR) are expressed in mature muscle, 39, 40 AdPK was expected to generate improved adenoviral transduction efficiencies in mature muscle because HSP is expressed in adult muscle. 42 Indeed, quantitative comparison of Ad and AdPK transduction levels in myoblast, myotube, and myofiber cell cultures in vitro and in normal mature and immature mouse skeletal muscle tissue in vivo showed that AdPK transduced muscle cells more efficiently than wild-type
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Ad. 52 The ability of the extended tropism adenovirus to attach to both the CAR and the heparan sulfate proteoglycan receptor may explain this improvement of adenoviral transduction in muscle cells at different maturities.
The improved transduction of muscle cells by AdPK made us question whether the extended vector can adequately circumvent the maturation-dependent adenoviral transducibility of mouse skeletal muscle. Therefore, we analyzed AdPK transduction efficiencies in muscle from immature and mature normal mice in vivo. Like the wild-type Ad vectors, AdPK was more efficient in transducing immature myofibers than normal mature myofibers. 43 It has been reported that the levels of heparan-containing attachment receptors are similar in immature and mature skeletal muscle; 42 therefore, factors other than viral receptors are probably involved in the reduced AdPK transducibility of mature mouse muscle.
AAV highly transduced muscle cells at different maturities:
It has been reported that AAV also uses the HSP receptor for viral transduction. 53 We found that AAV can transduce newborn and adult myofibers with a similar efficiency. 24 The ability of AAV to transduce mature myofibers leads us to hypothesize that the receptors are not the only factor involved in the maturation-dependent viral transduction of myofibers. Indeed, it is known that AAV used, at least in part, the heparan sulfate proteoglycan as an attachment receptor, and this receptor is expressed at high levels in mature skeletal muscle. 42 Although this can be used to explain the high level of AAV transduction in mature myofibers, it fails to explain why the modified tropism adenovirus (AdPK), which also attaches to the HSP receptor, cannot transduce mature myofibers with high efficiency. All these results suggest that the small size of the AAV particles (20 nm) in contrast to other, larger viral vectors, makes them compatible to penetrate the pores of a basal lamina (40 nm) surrounding the mature muscle fiber. Similarly, the modified tropism adenovirus, which can recognize both CAR and HSP, still cannot highly transduce mature myofibers because of the overall size of the adenoviral particles, which are still too big to penetrate the basal lamina and consequently transduce the mature myofibers.
Myoblasts play a major role in adenoviral transduction of myofibers: In this study, we have further determined that irradiation of the newborn skeletal muscle before viral injection influenced the level of adenoviral transduction without altering the expression and, more importantly, the function of the adenoviral receptors. Irradiation of newborn mice before viral injection was done to inactivate myoblasts within the newborn muscle. The irradiation before adenoviral injection (Ad, AdPK) significantly decreased the transduction efficiency even in newborn skeletal muscle. This result showed that Ad and AdPK transduction rely, at least in part, on myoblast mediation. In contrast, we observed that AAV does not require myoblast mediation and indeed can transduce newborn muscle even after irradiation. This result is consistent with our previous report. 24 It is possible that irradiation may affect the adenoviral receptors at the surface of myofibers. In order to rule out this hypothesis, we investigated the level of expression of integrins ␣v, ␤3 and ␤5 and CAR in newborn muscle with and without irradiation. We observed by using the real-time PCR combined with regular PCR and NIH image software that the irradiation has little effect on the level of adenoviral receptor expression in newborn muscle. More importantly, we investigated whether the receptor is still functional after irradiation by using the AAV and the modified tropism adenovirus, which both use the HSP as attachment receptors. We observed that the irradiation impaired the modified tropism adenoviral transduction in newborn muscle without affecting the level of transduction with AAV. These results suggest that the irradiation not only did not affect the number of viral receptors but also did not impair their function since AAV can still use the HSP receptors to transduce myofibers after irradiation. The inability of the modified tropism adenovirus to transduce newborn muscle after irradiation is probably related to the inactivation of the myoblasts, which cannot fuse with the myofibers.
In summary, based on these results, we conclude that myoblast quiescence and the development of the basal lamina with muscle maturation play a major role in the adenoviral transduction and that the viral receptor is not a major determinant in the maturation-dependent adenoviral gene transfer to skeletal muscle.
Material and methods Animals
Immature (up to 7 days old) and mature (at least 6 weeks old) normal mice (strain C57BL/10J, C57 BL/6J) were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). All animal experiments were performed in accordance with guidelines of the Institutional Animal Research and Care Committee (ARCC) at Children's Hospital of Pittsburgh (animal protocol 2/2000).
Viral vectors
The adenoviral vector (AdLacZ) used for these studies was E1/E3-deleted and contained a LacZ gene driven by the HCMV promoter 54 (viral titer 1 × 10 10 p.f.u./ml). Extended tropism PK adenovirus (AdPK) was engineered as previously described. 49 This vector (AdPK) also encoded for the LacZ gene under the control of the HCMV promoter. The titer of the viral suspension analyzed was 3 × 10 10 p.f.u./ml. The adenovirus-free AAV LacZ viral stocks (PXX2-LacZ) were made by using threeplasmid cotransfection and double CsCl purification according to the published method. 55 The PXX2-LacZ is an AAV-LacZ vector containing the cassette including the HCMV promoter driving the ␤-galactosidase reporter gene, followed by a polyadenylation signal (polyA).
In vitro experiments
Cultures of myoblasts were prepared from immature and mature mice using a method previously described. 9 The cell proliferation was performed in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 10% horse serum (HS), 0.5% chicken embryo extract (CEE), and 1% penicillin-streptomycin (PS) (all of which were purchased from Gibco BRL, Grand Island, NY, USA). In order to induce differentiation of myoblasts into myotubes, the proliferation medium was replaced by fusion medium, which consisted of DMEM supplemented with 1% FBS, 1% HS, and 1% PS, followed by 2 to 5 days of incubation at 37°C. Single myofibers were isolated from the extensor digitorum longus and from the soleus and gastrocnemius muscles by enzymatic dissociation in 0.2% collagenase type I (Sigma, St Louis, MO, USA) as previously described. 31, 43, 56 After dissociation, five to 10 single myofibers in 2 ml of medium (DMEM containing 10% HS, 2% l-glutamine, 1% CEE, and 1% PS) were plated in 12-well plates coated with 1 mg/ml Matrigel (Collaborative Biomedical Products, Bedford, MA, USA), and subsequently incubated at 37°C/5% CO 2 .
For viral transduction, myoblasts (2 × 10 6 cells), myotubes, and myofibers were rinsed in Hanks' balanced salt solution (HBSS) and incubated with adenoviral (MOI, 50) suspension in 1 ml of HBSS for 3 h at 37°C. After this initial incubation period, 2 ml of proliferating medium was added to the flasks for an additional 12 h at 37°C. The viral suspensions were then removed, and the cells were rinsed with HBSS and overlaid with proliferation medium. At 48 h after transduction, the cells were fixed in 1.5% gluteraldehyde (Sigma) and stained for ␤-galactosidase expression as described below.
In vivo experiments
For each viral vector, six normal (immature and mature) mice were analyzed. The mice were anesthetized using Metafane (Mallinckrodt Veterinary, Mundelein, IL, USA), and both gastrocnemius muscles were subsequently injected percutaneously with the viral suspension (1 × 10 7 p.f.u. in 30 l of HBSS) using a Hamilton syringe with a 26-gauge needle.
For the irradiation experiment, newborn mouse hindlimbs were exposed to 30 Gy of ␥-irradiation from a 137 Cs source (Clinac 600C; Varian Associates, Palo Alto, CA, USA) as previously described. 20 At 24 h after irradiation, gastrocnemius muscles of those mice and nonirradiated mice were percutaneously injected with the adenoviral, AdPK and adeno-associated viral suspension (six animals per group) as described above.
Mice injected with Ad and AdPK were killed 4 days after viral injection. Those injected with AAV were killed at either 4 days (immature) or 3 weeks (mature) after injection. Considering that AAV transduction of myofibers increases up to 3 weeks after injection, we used these two time-points to make sure that results at 4 days would not be different from those at 3 weeks. The injected muscles were isolated and frozen in liquid nitrogen-precooled isopentane. Serial cryostat sections (10 m) were subsequently analyzed for ␤-galactosidase activity.
Immunocytochemistry
Muscle sections were fixed with cold acetone (−20°C) for 2 min. The cell cultures were fixed in cold methanol (−20°C) for 1 min. After several rinses in TBS/TritonX-100, pH 7.4 (0.05 m Tris, 0.15 m NaCl, 1% Triton X-100), they were blocked with 10% horse serum for 30 min. The sections were then incubated overnight at 4°C in a humid chamber with the following primary antibodies: polyclonal rabbit anti-human integrin ␣v 1:100 (Chemicon, Temecula, CA, USA), polyclonal rabbit anti-human integrin ␤5 1:100 (Chemicon), and mouse RmcB antibody against CAR (gift from Dr JM Bergelson, Children's Hospital of Philadelphia). After three rinses in TBS/Triton X-100, pH 7.4, the secondary antibody Cy3-conjugated F(ab) fragment of sheep anti-rabbit (1:200, Sigma) was applied for 30 min at room temperature. We used aorta and liver tissues as positive controls for integrin and CAR, respectively. Stainings without primary antibodies were also used as negative controls.
After the staining, we used the NIH image software (Scion Image, Frederick, MD, USA) to semiquantitate the integrin expression level. We used a representative sample for the figure from six sections obtained from six mice, or six wells per cell culture. The fluorescence intensity detected in the negative control specimen groups was measured and subtracted from that of the experimental groups. Data were processed as described in the statistical analysis.
␤-Galactosidase histochemistry
The muscle sections or cultures were fixed in 1.5% gluteraldehyde in phosphate-buffered saline (PBS, pH 7.4; Boehringer Mannheim, Indianapolis, IN, USA) for 1 min. ␤-Galactosidase activity was subsequently determined by LacZ staining for 2 to 12 h at 37°C with an X-gal substrate solution (0.35 mg/ml of 5-bromo-4-chloro-3-indolyl-␤-dgalactopyranoside, 1.3 mm MgCl 2 , 3 mm K 3 Fe(CN) 6 , and 3 mm K 4 Fe(CN) 6 in 1 × PBS at pH 7.4). Finally, the sections were counterstained with hematoxylin and eosin (Sigma).
Assay for ␤-galactosidase activity
This technique was performed in order to achieve a better quantitation and comparison of the gene expression levels in the injected muscles. 57 The injected muscles were frozen in liquid nitrogen and homogenized in 0.25 m TrisHCl (pH 7.8), the homogenates were disrupted by three cycles of freeze/thaw, and the supernatants were collected. 30 l out of the cell extract was mixed with 66 l of 4 mg/ml ONPG (O-nitrophenyl-␤-d-galactopyranoside; Sigma) dissolved in 0.1 m sodium phosphate (pH 7.4), 3 l of 4.5 m ␤-mercaptoethanol dissolved in 0.1 m MgCl 2 , and 201 l of 0.1 m sodium phosphate. The mixture was then incubated at 37°C for 30 min. The reaction was stopped by adding 500 l of 1 m Na 2 CO 3 , and the optical density (OD) was read on a spectrophotometer at a wavelength of 420 nm. The level of ␤-galactosidase activity (ng/mg tissue) was extrapolated on a calibration curve that converted the OD at 420 nm to the concentration of ␤-galactosidase enzyme in the transduced muscles. Average data were calculated from six mice in each group. We used the Student's t test to compare the irradiated group with nonirradiated group for the Ad, AdPK and AAV.
RT-PCR and real-time PCR analysis of adenoviral receptor levels The total RNA was isolated from gastrocnemius muscles of normal mice (strain C57BL/6J) using the TRIzol reagent (Life Technologies, Gaithersburg, MD, USA). Reverse transcription (RT) was carried out using SuperScript Preamplification System for First Strand cDNA Synthesis (Life Technologies) according to the manufacturer's instructions. Briefly, 100 ng of random hexamers was annealed to 1 g of total RNA at 70°C for 10 min, then chilled on ice.
Reverse transcription was carried out with 2 l of 10 × PCR buffer, 2 l of 25 mm MgCl 2 , 1 l of 10 mm dNTP mix, 2 l of 0.1 m DTT, and 200 U SuperScript II reverse transcriptase. The reaction mixture was incubated for 50 min at 42°C.
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Polymerase chain reaction (PCR) amplification of CAR and integrin (␣v, ␤3 and ␤5) transcripts was performed in a 50 l reaction mixture containing 2 l of RT-material, 5 U/100 l Taq DNA polymerase (Life Technologies), and 1.5 mm MgCl 2 . The sequences of the primers for amplification of the different receptors are as follows: CAR-forward: 5ЈTGGCCCTTGTGCTCATC3Ј, reverse: 5ЈGACTTGGTTATACTGCGTCTTG3Ј; integrin ␣v-forward: 5ЈCCAGCCTGGGATTGTAGAAG3Ј, reverse: 5ЈACT CCAGTGGGTCATCTTTG3Ј; integrin ␤3-forward: 5ЈTCT GGCTGTGAGTCCTGTGT3Ј, reverse: 5ЈGCCTCACT GACTGGGAACTC3Ј; integrin ␤5-forward: 5ЈTCGTGTG AAGAATGCCTGTT3Ј, reverse: 5ЈGCTGGACTCT CAATCTCACC3Ј.
The following PCR parameters were used: 94°C for 45 s, 56°C (for CAR) or 53°C (for integrins) for 60 s, 72°C for 90 s for 35 cycles. For CAR real-time PCR, a LightCycler (Roche Molecular Biochemicals, Indianapolis, IN, USA) was used with the kit LightCycler DNA Master SYBR Green I (Roche Molecular Biochemicals). 20 l of the reaction mixture was used with 3.5 mm MgCl 2 , annealing temperature 54°C. PCR products were analyzed by agarose-TAE-ethidium bromide gel and melting curve (real-time PCR). Quantitation of CAR was performed by calibrating the relative amount of CAR mRNA against ␤-actin. The expected product sizes were as follows: CAR: 221 bp; integrin ␣v: 105 bp; integrin ␤3: 115 bp; integrin ␤5: 126 bp. To exclude genomic DNA contamination, two controls were used: (1) parallel reverse transcription without reverse transcriptase, and (2) amplification of ␤-actin using a primer set that spans an intron (Clontech, Palo Alto, CA, USA). The ␤-actin was also used as a reference for quantitation. We also performed PCR using water instead of RT transcripts as an additional control. To get further quantitative information, PCR bands were scanned and analyzed using NIH image software (Scion image, Frederick, MD, USA) among the different groups: newborn versus adult; nonirradiated versus irradiated. Each group had six mice. Standard deviations were calculated based on these sixanimal groups.
Statistical analysis
Results are expressed as mean ± standard deviation. The Student's t test was used to compare data. P Ͻ 0.05 was considered significant.
